BLMWF yields 286.90% · JNJ yields 2.14%● Live data
📍 BLMWF pulled ahead of the other in Year 1
Combined, BLMWF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BLMWF + JNJ for your $10,000?
BluMetric Environmental Inc. provides sustainable solutions for environmental issues in Canada and internationally. The company offers consulting services and water treatment systems services in the fields of environmental geosciences and engineering, industrial hygiene, occupational health and safety, renewable energy, water and wastewater treatment, and environmental contracting and management. It also provides environmental site assessment and remediation services, environmental engineering solutions, occupational hygiene and safety, geomatics, and watertech production, operations and maintenance services. In addition, the company offers shipboard reverse osmosis desalinator systems; reverse osmosis water purification units; shipboard oily water separator; sub-unit water purification system; portable water purification systems; and mobile wastewater treatment plants. It serves commercial and industrial customers, military clients, mining, and governments. BluMetric Environmental Inc. was founded in 1976 and is headquartered in Ottawa, Canada.
Full BLMWF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.